Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. experienced a year-over-year revenue increase of 1.6%, surpassing previous growth forecasts, which was significantly impacted by the timing of deals. The company anticipates growth in its Other category, driven by innovations like AtmosAuto and Dolby Cinema, suggesting a positive outlook for future revenue streams. Furthermore, the successful adoption of its audio and imaging technologies, coupled with the strategic expansion of premium large format (PLF) cinema offerings, positions Dolby for substantial long-term revenue growth, particularly as volume recovery may lead to increased per-unit royalties.

Bears say

Dolby Laboratories Inc. is projected to experience a challenging financial quarter, with estimates indicating a 7.5% year-over-year decline in licensing revenue and a 5.7% drop in products and services for the December quarter. Gross margins have also decreased to 89.8% from 90.8%, driven by lower margins in the company's product and service lines, alongside an expectation of a high-single-digit revenue decline for fiscal 2026. Additionally, persistent headwinds from reduced device volumes and overall declines in the PC and consumer electronics sectors are anticipated to negatively impact revenue growth moving forward.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.